| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | myosin light chain binding | 2.66e-05 | 8 | 20 | 2 | GO:0032027 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 1.86e-04 | 560 | 20 | 5 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 1.96e-04 | 566 | 20 | 5 | GO:0001216 | |
| GeneOntologyMolecularFunction | chromatin binding | 6.68e-04 | 739 | 20 | 5 | GO:0003682 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 2.39e-03 | 582 | 20 | 4 | GO:0140297 | |
| GeneOntologyMolecularFunction | myosin binding | 3.24e-03 | 85 | 20 | 2 | GO:0017022 | |
| GeneOntologyBiologicalProcess | endocardial cell differentiation | 1.34e-05 | 6 | 20 | 2 | GO:0060956 | |
| GeneOntologyBiologicalProcess | cardiac endothelial cell differentiation | 2.49e-05 | 8 | 20 | 2 | GO:0003348 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | 2.52e-05 | 1390 | 20 | 8 | GO:0045944 | |
| GeneOntologyBiologicalProcess | endodermal cell fate specification | 4.89e-05 | 11 | 20 | 2 | GO:0001714 | |
| GeneOntologyBiologicalProcess | endocardium development | 6.92e-05 | 13 | 20 | 2 | GO:0003157 | |
| GeneOntologyBiologicalProcess | endodermal cell fate commitment | 1.35e-04 | 18 | 20 | 2 | GO:0001711 | |
| GeneOntologyBiologicalProcess | glial cell fate commitment | 1.51e-04 | 19 | 20 | 2 | GO:0021781 | |
| GeneOntologyBiologicalProcess | stem cell differentiation | 1.91e-04 | 306 | 20 | 4 | GO:0048863 | |
| HumanPheno | Alobar holoprosencephaly | 1.33e-07 | 9 | 7 | 3 | HP:0006988 | |
| HumanPheno | Holoprosencephaly | 1.91e-06 | 80 | 7 | 4 | HP:0001360 | |
| HumanPheno | Butterfly vertebrae | 2.09e-06 | 21 | 7 | 3 | HP:0003316 | |
| HumanPheno | Proboscis | 2.09e-06 | 21 | 7 | 3 | HP:0012806 | |
| HumanPheno | Vertebral clefting | 1.66e-05 | 41 | 7 | 3 | HP:0008428 | |
| HumanPheno | Expressive language delay | 4.27e-05 | 56 | 7 | 3 | HP:0002474 | |
| HumanPheno | Median cleft palate | 4.27e-05 | 56 | 7 | 3 | HP:0009099 | |
| HumanPheno | Median cleft upper lip | 4.27e-05 | 56 | 7 | 3 | HP:0000161 | |
| HumanPheno | Language delay | 4.27e-05 | 56 | 7 | 3 | HP:0002336 | |
| HumanPheno | Median cleft lip and palate | 4.27e-05 | 56 | 7 | 3 | HP:0008501 | |
| HumanPheno | Semilobar holoprosencephaly | 5.80e-05 | 9 | 7 | 2 | HP:0002507 | |
| HumanPheno | Hemivertebrae | 5.81e-05 | 62 | 7 | 3 | HP:0002937 | |
| HumanPheno | Diabetes insipidus | 6.39e-05 | 64 | 7 | 3 | HP:0000873 | |
| HumanPheno | Abnormality of the hypothalamus | 9.88e-05 | 74 | 7 | 3 | HP:0002443 | |
| HumanPheno | Gastrointestinal atresia | 1.96e-04 | 93 | 7 | 3 | HP:0002589 | |
| HumanPheno | Aspiration pneumonia | 2.08e-04 | 95 | 7 | 3 | HP:0011951 | |
| HumanPheno | Optic nerve hypoplasia | 2.97e-04 | 107 | 7 | 3 | HP:0000609 | |
| HumanPheno | Aplasia of the falx cerebri | 3.04e-04 | 20 | 7 | 2 | HP:0010654 | |
| HumanPheno | Septo-optic dysplasia | 3.04e-04 | 20 | 7 | 2 | HP:0100842 | |
| HumanPheno | Abnormal septum pellucidum morphology | 3.40e-04 | 112 | 7 | 3 | HP:0007375 | |
| HumanPheno | Cyclopia | 3.69e-04 | 22 | 7 | 2 | HP:0009914 | |
| HumanPheno | Single naris | 3.69e-04 | 22 | 7 | 2 | HP:0009932 | |
| HumanPheno | Ureteropelvic junction obstruction | 4.04e-04 | 23 | 7 | 2 | HP:0000074 | |
| HumanPheno | Duplicated collecting system | 4.40e-04 | 24 | 7 | 2 | HP:0000081 | |
| HumanPheno | Aplasia/Hypoplasia of the nares | 4.40e-04 | 24 | 7 | 2 | HP:0100597 | |
| HumanPheno | Growth hormone and pituitary abnormality | 4.54e-04 | 319 | 7 | 4 | HP:0000844 | |
| HumanPheno | Abnormality of the pituitary gland | 4.54e-04 | 319 | 7 | 4 | HP:0000838 | |
| HumanPheno | Abnormal heart rate variability | 4.78e-04 | 25 | 7 | 2 | HP:0031860 | |
| HumanPheno | Abnormal diencephalon morphology | 5.16e-04 | 129 | 7 | 3 | HP:0010662 | |
| HumanPheno | Abnormal lateral ventricle morphology | 5.16e-04 | 129 | 7 | 3 | HP:0030047 | |
| HumanPheno | Lobar holoprosencephaly | 5.18e-04 | 26 | 7 | 2 | HP:0006870 | |
| HumanPheno | Depressed nasal ridge | 5.39e-04 | 131 | 7 | 3 | HP:0000457 | |
| HumanPheno | Abnormality of the falx cerebri | 5.59e-04 | 27 | 7 | 2 | HP:0010653 | |
| HumanPheno | Single central incisor | 5.59e-04 | 27 | 7 | 2 | HP:0001573 | |
| HumanPheno | Solitary median maxillary central incisor | 5.59e-04 | 27 | 7 | 2 | HP:0006315 | |
| HumanPheno | Oromotor apraxia | 6.02e-04 | 28 | 7 | 2 | HP:0007301 | |
| HumanPheno | Abnormal dura mater morphology | 6.02e-04 | 28 | 7 | 2 | HP:0010652 | |
| HumanPheno | Decreased response to growth hormone stimulation test | 6.02e-04 | 136 | 7 | 3 | HP:0000824 | |
| HumanPheno | Abnormal renal collecting system morphology | 6.91e-04 | 30 | 7 | 2 | HP:0004742 | |
| HumanPheno | Panhypopituitarism | 7.39e-04 | 31 | 7 | 2 | HP:0000871 | |
| HumanPheno | Hypotelorism | 7.42e-04 | 146 | 7 | 3 | HP:0000601 | |
| HumanPheno | Abnormality of the anterior pituitary | 7.71e-04 | 366 | 7 | 4 | HP:0011747 | |
| HumanPheno | Coarctation of aorta | 8.03e-04 | 150 | 7 | 3 | HP:0001680 | |
| HumanPheno | Ureteral stenosis | 8.38e-04 | 33 | 7 | 2 | HP:0000071 | |
| HumanPheno | Abnormal response to endocrine stimulation test | 8.51e-04 | 153 | 7 | 3 | HP:0031073 | |
| HumanPheno | Abnormal growth hormone level | 8.67e-04 | 154 | 7 | 3 | HP:0032367 | |
| HumanPheno | Abnormal endocrine physiology | 9.01e-04 | 156 | 7 | 3 | HP:0031072 | |
| HumanPheno | Abnormal pituitary gland morphology | 9.73e-04 | 389 | 7 | 4 | HP:0012503 | |
| HumanPheno | Abnormal morphology of the olfactory bulb | 9.97e-04 | 36 | 7 | 2 | HP:0040327 | |
| HumanPheno | Vertebral segmentation defect | 1.01e-03 | 162 | 7 | 3 | HP:0003422 | |
| HumanPheno | Bifid uvula | 1.10e-03 | 167 | 7 | 3 | HP:0000193 | |
| HumanPheno | Ureteral obstruction | 1.17e-03 | 39 | 7 | 2 | HP:0006000 | |
| HumanPheno | Hydrocephalus | 1.32e-03 | 421 | 7 | 4 | HP:0000238 | |
| HumanPheno | Central apnea | 1.36e-03 | 42 | 7 | 2 | HP:0002871 | |
| HumanPheno | Chronic lung disease | 1.36e-03 | 42 | 7 | 2 | HP:0006528 | |
| HumanPheno | Anterior hypopituitarism | 1.41e-03 | 182 | 7 | 3 | HP:0000830 | |
| HumanPheno | Temperature instability | 1.42e-03 | 43 | 7 | 2 | HP:0005968 | |
| HumanPheno | Iris coloboma | 1.43e-03 | 183 | 7 | 3 | HP:0000612 | |
| HumanPheno | Cleft upper lip | 1.43e-03 | 183 | 7 | 3 | HP:0000204 | |
| HumanPheno | Sloping forehead | 1.55e-03 | 188 | 7 | 3 | HP:0000340 | |
| HumanPheno | Duodenal atresia | 1.56e-03 | 45 | 7 | 2 | HP:0002247 | |
| HumanPheno | Sleep-wake cycle disturbance | 1.56e-03 | 45 | 7 | 2 | HP:0006979 | |
| HumanPheno | Maternal diabetes | 1.56e-03 | 45 | 7 | 2 | HP:0009800 | |
| HumanPheno | Hypopituitarism | 1.62e-03 | 191 | 7 | 3 | HP:0040075 | |
| HumanPheno | Abnormality of the hypothalamus-pituitary axis | 1.68e-03 | 449 | 7 | 4 | HP:0000864 | |
| HumanPheno | Infantile axial hypotonia | 1.77e-03 | 48 | 7 | 2 | HP:0009062 | |
| HumanPheno | Abnormal uvula morphology | 1.78e-03 | 197 | 7 | 3 | HP:0000172 | |
| HumanPheno | Hypoplastic left heart | 1.85e-03 | 49 | 7 | 2 | HP:0004383 | |
| HumanPheno | Congenital malformation of the left heart | 2.00e-03 | 51 | 7 | 2 | HP:0045017 | |
| HumanPheno | Constipation | 2.03e-03 | 472 | 7 | 4 | HP:0002019 | |
| HumanPheno | Abnormal hypothalamus physiology | 2.16e-03 | 53 | 7 | 2 | HP:0012285 | |
| HumanPheno | Abnormal vertebral morphology | 2.21e-03 | 483 | 7 | 4 | HP:0003468 | |
| HumanPheno | Hypoplastic heart | 2.24e-03 | 54 | 7 | 2 | HP:0001961 | |
| HumanPheno | Infantile muscular hypotonia | 2.41e-03 | 219 | 7 | 3 | HP:0008947 | |
| HumanPheno | Atresia of the external auditory canal | 2.58e-03 | 58 | 7 | 2 | HP:0000413 | |
| HumanPheno | Preauricular pit | 2.85e-03 | 61 | 7 | 2 | HP:0004467 | |
| HumanPheno | Abnormal intestine morphology | 2.90e-03 | 1459 | 7 | 6 | HP:0002242 | |
| HumanPheno | Abnormal number of incisors | 3.04e-03 | 63 | 7 | 2 | HP:0011064 | |
| HumanPheno | Cleft soft palate | 3.06e-03 | 238 | 7 | 3 | HP:0000185 | |
| HumanPheno | Congenital malformation of the great arteries | 3.11e-03 | 529 | 7 | 4 | HP:0011603 | |
| HumanPheno | Cleft secondary palate | 3.14e-03 | 240 | 7 | 3 | HP:0410004 | |
| HumanPheno | Cleft lip | 3.14e-03 | 240 | 7 | 3 | HP:0410030 | |
| HumanPheno | Ureteral duplication | 3.43e-03 | 67 | 7 | 2 | HP:0000073 | |
| HumanPheno | Intestinal atresia | 3.43e-03 | 67 | 7 | 2 | HP:0011100 | |
| HumanPheno | Periauricular skin pits | 3.43e-03 | 67 | 7 | 2 | HP:0100277 | |
| HumanPheno | Anteriorly placed anus | 3.53e-03 | 68 | 7 | 2 | HP:0001545 | |
| HumanPheno | Abnormal uvea morphology | 3.61e-03 | 965 | 7 | 5 | HP:0000553 | |
| HumanPheno | Renal duplication | 3.63e-03 | 69 | 7 | 2 | HP:0000075 | |
| HumanPheno | Absent septum pellucidum | 3.63e-03 | 69 | 7 | 2 | HP:0001331 | |
| HumanPheno | Abdominal organ duplication | 3.63e-03 | 69 | 7 | 2 | HP:0005217 | |
| Domain | HMG_box | 2.38e-05 | 53 | 20 | 3 | PF00505 | |
| Domain | HMG | 2.52e-05 | 54 | 20 | 3 | SM00398 | |
| Domain | - | 2.66e-05 | 55 | 20 | 3 | 1.10.30.10 | |
| Domain | HMG_box_dom | 4.40e-05 | 65 | 20 | 3 | IPR009071 | |
| Domain | MYB_LIKE | 7.48e-04 | 38 | 20 | 2 | PS50090 | |
| Domain | SANT | 1.29e-03 | 50 | 20 | 2 | SM00717 | |
| Domain | SANT/Myb | 1.40e-03 | 52 | 20 | 2 | IPR001005 | |
| Domain | HMG_BOX_2 | 1.51e-03 | 54 | 20 | 2 | PS50118 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 1.34e-05 | 42 | 16 | 3 | M27272 | |
| Pathway | WP_MESODERMAL_COMMITMENT_PATHWAY | 2.19e-05 | 153 | 16 | 4 | M39546 | |
| Pathway | WP_CARDIAC_PROGENITOR_DIFFERENTIATION | 2.71e-05 | 53 | 16 | 3 | M39681 | |
| Pathway | REACTOME_FORMATION_OF_THE_ANTERIOR_NEURAL_PLATE | 6.60e-05 | 11 | 16 | 2 | M48031 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 3.03e-04 | 301 | 16 | 4 | MM15983 | |
| Pathway | REACTOME_GASTRULATION | 3.84e-04 | 129 | 16 | 3 | M46433 | |
| Pathway | WP_ENDODERM_DIFFERENTIATION | 5.20e-04 | 143 | 16 | 3 | M39591 | |
| Pubmed | 1.42e-07 | 83 | 20 | 4 | 28794006 | ||
| Pubmed | 2.49e-07 | 22 | 20 | 3 | 23247143 | ||
| Pubmed | 2.86e-07 | 23 | 20 | 3 | 20713518 | ||
| Pubmed | Unique and redundant roles of SOX2 and SOX17 in regulating the germ cell tumor fate. | 3.14e-07 | 2 | 20 | 2 | 31583686 | |
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 31997540 | ||
| Pubmed | 3.71e-07 | 25 | 20 | 3 | 20301702 | ||
| Pubmed | 4.19e-07 | 26 | 20 | 3 | 22992956 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | 4.65e-07 | 908 | 20 | 7 | 19274049 | |
| Pubmed | 4.75e-07 | 282 | 20 | 5 | 23667531 | ||
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 25868860 | ||
| Pubmed | Mechanism and Role of SOX2 Repression in Seminoma: Relevance to Human Germline Specification. | 9.42e-07 | 3 | 20 | 2 | 27132888 | |
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 19328208 | ||
| Pubmed | MLL4 Regulates the Progression of Non-Small-Cell Lung Cancer by Regulating the PI3K/AKT/SOX2 Axis. | 1.88e-06 | 4 | 20 | 2 | 36701842 | |
| Pubmed | Neuregulin1 and ErbB expression in the uninjured and regenerating olfactory mucosa. | 1.88e-06 | 4 | 20 | 2 | 26474499 | |
| Pubmed | 2.51e-06 | 396 | 20 | 5 | 26687479 | ||
| Pubmed | G9a regulates temporal preimplantation developmental program and lineage segregation in blastocyst. | 3.14e-06 | 5 | 20 | 2 | 29745895 | |
| Pubmed | Neural tube closure depends on expression of Grainyhead-like 3 in multiple tissues. | 3.14e-06 | 5 | 20 | 2 | 29397878 | |
| Pubmed | 3.14e-06 | 5 | 20 | 2 | 19736317 | ||
| Pubmed | SOX7 and GATA-4 are competitive activators of Fgf-3 transcription. | 4.71e-06 | 6 | 20 | 2 | 15082719 | |
| Pubmed | Plakoglobin is a mechanoresponsive regulator of naive pluripotency. | 4.71e-06 | 6 | 20 | 2 | 37419903 | |
| Pubmed | 4.71e-06 | 6 | 20 | 2 | 29217752 | ||
| Pubmed | 6.59e-06 | 7 | 20 | 2 | 18755297 | ||
| Pubmed | 6.59e-06 | 7 | 20 | 2 | 17875931 | ||
| Pubmed | Dominant and context-specific control of endodermal organ allocation by Ptf1a. | 8.78e-06 | 8 | 20 | 2 | 25371369 | |
| Pubmed | Oct4 switches partnering from Sox2 to Sox17 to reinterpret the enhancer code and specify endoderm. | 8.78e-06 | 8 | 20 | 2 | 23474895 | |
| Pubmed | 1.13e-05 | 9 | 20 | 2 | 26691508 | ||
| Pubmed | Lima1 mediates the pluripotency control of membrane dynamics and cellular metabolism. | 1.41e-05 | 10 | 20 | 2 | 35105859 | |
| Pubmed | 1.41e-05 | 10 | 20 | 2 | 27072135 | ||
| Pubmed | 1.41e-05 | 10 | 20 | 2 | 20123909 | ||
| Pubmed | 1.52e-05 | 268 | 20 | 4 | 33640491 | ||
| Pubmed | The Zic2 gene directs the formation and function of node cilia to control cardiac situs. | 2.07e-05 | 12 | 20 | 2 | 24585447 | |
| Pubmed | 2.07e-05 | 12 | 20 | 2 | 23728800 | ||
| Pubmed | TMEM132A regulates mouse hindgut morphogenesis and caudal development. | 2.44e-05 | 13 | 20 | 2 | 37390294 | |
| Pubmed | Deciphering the Sox-Oct partner code by quantitative cooperativity measurements. | 2.44e-05 | 13 | 20 | 2 | 22344693 | |
| Pubmed | 2.44e-05 | 13 | 20 | 2 | 16510874 | ||
| Pubmed | 2.44e-05 | 13 | 20 | 2 | 12194848 | ||
| Pubmed | A Sprouty4 reporter to monitor FGF/ERK signaling activity in ESCs and mice. | 2.44e-05 | 13 | 20 | 2 | 29964027 | |
| Pubmed | Oct4 cell-autonomously promotes primitive endoderm development in the mouse blastocyst. | 2.44e-05 | 13 | 20 | 2 | 23747191 | |
| Pubmed | 2.85e-05 | 14 | 20 | 2 | 8921394 | ||
| Pubmed | 3.28e-05 | 15 | 20 | 2 | 16510875 | ||
| Pubmed | 3.28e-05 | 15 | 20 | 2 | 30735538 | ||
| Pubmed | GATA6 levels modulate primitive endoderm cell fate choice and timing in the mouse blastocyst. | 3.28e-05 | 15 | 20 | 2 | 24835466 | |
| Pubmed | 3.28e-05 | 15 | 20 | 2 | 28512199 | ||
| Pubmed | 3.28e-05 | 15 | 20 | 2 | 31420575 | ||
| Pubmed | Pluripotency factors regulate definitive endoderm specification through eomesodermin. | 3.75e-05 | 16 | 20 | 2 | 21245162 | |
| Pubmed | 3.75e-05 | 16 | 20 | 2 | 33929320 | ||
| Pubmed | Dual lineage-specific expression of Sox17 during mouse embryogenesis. | 3.75e-05 | 16 | 20 | 2 | 22865702 | |
| Pubmed | 3.75e-05 | 16 | 20 | 2 | 18332127 | ||
| Pubmed | A balanced Oct4 interactome is crucial for maintaining pluripotency. | 3.75e-05 | 16 | 20 | 2 | 35171666 | |
| Pubmed | Hindgut defects and transformation of the gastro-intestinal tract in Tcf4(-/-)/Tcf1(-/-) embryos. | 3.75e-05 | 16 | 20 | 2 | 15057272 | |
| Pubmed | 4.25e-05 | 17 | 20 | 2 | 31171776 | ||
| Pubmed | Spatio-temporal expression of Sox genes in murine palatogenesis. | 4.25e-05 | 17 | 20 | 2 | 27241892 | |
| Pubmed | 4.25e-05 | 17 | 20 | 2 | 22578469 | ||
| Pubmed | 4.25e-05 | 17 | 20 | 2 | 29915126 | ||
| Pubmed | 4.78e-05 | 18 | 20 | 2 | 27957530 | ||
| Pubmed | 4.78e-05 | 18 | 20 | 2 | 26864488 | ||
| Pubmed | Neurog3-dependent pancreas dysgenesis causes ectopic pancreas in Hes1 mutant mice. | 4.78e-05 | 18 | 20 | 2 | 30093553 | |
| Pubmed | Cell-Intrinsic Control of Interneuron Migration Drives Cortical Morphogenesis. | 5.34e-05 | 19 | 20 | 2 | 29474907 | |
| Pubmed | Post-gastrulation synthetic embryos generated ex utero from mouse naive ESCs. | 5.34e-05 | 19 | 20 | 2 | 35988542 | |
| Pubmed | 5.34e-05 | 19 | 20 | 2 | 35177595 | ||
| Pubmed | 5.93e-05 | 20 | 20 | 2 | 25340657 | ||
| Pubmed | 5.93e-05 | 20 | 20 | 2 | 29412136 | ||
| Pubmed | Wntless is required for peripheral lung differentiation and pulmonary vascular development. | 5.93e-05 | 20 | 20 | 2 | 23523683 | |
| Pubmed | 6.55e-05 | 21 | 20 | 2 | 27348588 | ||
| Pubmed | Expression of Sox transcription factors in the developing mouse pancreas. | 6.55e-05 | 21 | 20 | 2 | 12815626 | |
| Pubmed | Schwann cell myelination requires integration of laminin activities. | 6.55e-05 | 21 | 20 | 2 | 22767514 | |
| Pubmed | Characterization of a common progenitor pool of the epicardium and myocardium. | 6.55e-05 | 21 | 20 | 2 | 33414188 | |
| Pubmed | Embryo model completes gastrulation to neurulation and organogenesis. | 7.21e-05 | 22 | 20 | 2 | 36007540 | |
| Pubmed | Zic2-dependent axon midline avoidance controls the formation of major ipsilateral tracts in the CNS. | 7.89e-05 | 23 | 20 | 2 | 24360543 | |
| Pubmed | Rap1 controls epiblast morphogenesis in sync with the pluripotency states transition. | 7.89e-05 | 23 | 20 | 2 | 35998584 | |
| Pubmed | 7.89e-05 | 23 | 20 | 2 | 9225980 | ||
| Pubmed | 8.61e-05 | 24 | 20 | 2 | 39047740 | ||
| Pubmed | Crucial role for Mst1 and Mst2 kinases in early embryonic development of the mouse. | 9.35e-05 | 25 | 20 | 2 | 19786569 | |
| Pubmed | A cluster of three long-range enhancers directs regional Shh expression in the epithelial linings. | 9.35e-05 | 25 | 20 | 2 | 19369396 | |
| Pubmed | 9.35e-05 | 25 | 20 | 2 | 36046192 | ||
| Pubmed | LRP2 Acts as SHH Clearance Receptor to Protect the Retinal Margin from Mitogenic Stimuli. | 1.01e-04 | 26 | 20 | 2 | 26439398 | |
| Pubmed | 1.09e-04 | 27 | 20 | 2 | 36197846 | ||
| Pubmed | 1.09e-04 | 27 | 20 | 2 | 23740937 | ||
| Pubmed | 1.09e-04 | 27 | 20 | 2 | 29386106 | ||
| Pubmed | 1.09e-04 | 27 | 20 | 2 | 33760820 | ||
| Pubmed | Cripto is essential to capture mouse epiblast stem cell and human embryonic stem cell pluripotency. | 1.09e-04 | 27 | 20 | 2 | 27586544 | |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 1.17e-04 | 167 | 20 | 3 | 20362541 | |
| Pubmed | Mediator and cohesin connect gene expression and chromatin architecture. | 1.18e-04 | 28 | 20 | 2 | 20720539 | |
| Pubmed | 1.26e-04 | 29 | 20 | 2 | 18794329 | ||
| Pubmed | 1.26e-04 | 29 | 20 | 2 | 25336744 | ||
| Pubmed | 1.45e-04 | 31 | 20 | 2 | 30254141 | ||
| Pubmed | 1.45e-04 | 31 | 20 | 2 | 30305289 | ||
| Pubmed | Specific functions for ERK/MAPK signaling during PNS development. | 1.45e-04 | 31 | 20 | 2 | 21220101 | |
| Pubmed | Critical role of the p400/mDomino chromatin-remodeling ATPase in embryonic hematopoiesis. | 1.54e-04 | 32 | 20 | 2 | 17535249 | |
| Pubmed | A SOX17-PDGFB signaling axis regulates aortic root development. | 1.74e-04 | 34 | 20 | 2 | 35831318 | |
| Pubmed | Robo signalling controls pancreatic progenitor identity by regulating Tead transcription factors. | 1.74e-04 | 34 | 20 | 2 | 30504829 | |
| Pubmed | Wnt5a and Wnt11 regulate mammalian anterior-posterior axis elongation. | 1.85e-04 | 35 | 20 | 2 | 25813538 | |
| Pubmed | 2.42e-04 | 40 | 20 | 2 | 28323616 | ||
| Pubmed | NOTCH activation interferes with cell fate specification in the gastrulating mouse embryo. | 2.42e-04 | 40 | 20 | 2 | 26534985 | |
| Pubmed | Identification of molecular compartments and genetic circuitry in the developing mammalian kidney. | 2.42e-04 | 40 | 20 | 2 | 22510988 | |
| Pubmed | SOX4 regulates gonad morphogenesis and promotes male germ cell differentiation in mice. | 2.54e-04 | 41 | 20 | 2 | 28118982 | |
| Pubmed | 2.67e-04 | 42 | 20 | 2 | 23863479 | ||
| Pubmed | NANOG initiates epiblast fate through the coordination of pluripotency genes expression. | 3.20e-04 | 46 | 20 | 2 | 35729116 | |
| Pubmed | Global expression analysis of gene regulatory pathways during endocrine pancreatic development. | 4.58e-04 | 55 | 20 | 2 | 14660441 | |
| Pubmed | 4.62e-04 | 650 | 20 | 4 | 38777146 | ||
| Interaction | KRT13 interactions | 4.70e-06 | 116 | 20 | 4 | int:KRT13 | |
| Interaction | SMARCE1 interactions | 7.36e-06 | 287 | 20 | 5 | int:SMARCE1 | |
| Interaction | POU5F1 interactions | 1.58e-05 | 584 | 20 | 6 | int:POU5F1 | |
| Interaction | HNF1B interactions | 3.30e-05 | 190 | 20 | 4 | int:HNF1B | |
| Interaction | H2BC3 interactions | 3.91e-05 | 406 | 20 | 5 | int:H2BC3 | |
| Interaction | DBN1 interactions | 4.44e-05 | 417 | 20 | 5 | int:DBN1 | |
| Interaction | WDR82 interactions | 5.15e-05 | 213 | 20 | 4 | int:WDR82 | |
| Interaction | HIGD1A interactions | 5.39e-05 | 75 | 20 | 3 | int:HIGD1A | |
| Interaction | CAPRIN1 interactions | 6.45e-05 | 451 | 20 | 5 | int:CAPRIN1 | |
| Interaction | NFIX interactions | 6.59e-05 | 227 | 20 | 4 | int:NFIX | |
| Interaction | POLDIP3 interactions | 7.79e-05 | 237 | 20 | 4 | int:POLDIP3 | |
| Interaction | PRR12 interactions | 8.69e-05 | 88 | 20 | 3 | int:PRR12 | |
| Interaction | TUBA1B interactions | 1.03e-04 | 498 | 20 | 5 | int:TUBA1B | |
| Interaction | HOXA5 interactions | 1.06e-04 | 94 | 20 | 3 | int:HOXA5 | |
| Interaction | DNTTIP1 interactions | 1.09e-04 | 95 | 20 | 3 | int:DNTTIP1 | |
| Interaction | ACTG1 interactions | 1.26e-04 | 520 | 20 | 5 | int:ACTG1 | |
| Interaction | YWHAG interactions | 1.30e-04 | 1248 | 20 | 7 | int:YWHAG | |
| Interaction | YWHAE interactions | 1.36e-04 | 1256 | 20 | 7 | int:YWHAE | |
| Interaction | MIDEAS interactions | 1.60e-04 | 108 | 20 | 3 | int:MIDEAS | |
| Interaction | MYL6B interactions | 1.60e-04 | 108 | 20 | 3 | int:MYL6B | |
| Interaction | ARID3B interactions | 1.83e-04 | 113 | 20 | 3 | int:ARID3B | |
| Interaction | MRPS23 interactions | 1.84e-04 | 296 | 20 | 4 | int:MRPS23 | |
| Interaction | MRPS18B interactions | 2.11e-04 | 307 | 20 | 4 | int:MRPS18B | |
| Interaction | GLIS3 interactions | 2.14e-04 | 22 | 20 | 2 | int:GLIS3 | |
| Interaction | SEPSECS interactions | 2.34e-04 | 23 | 20 | 2 | int:SEPSECS | |
| Interaction | CPLANE1 interactions | 2.77e-04 | 25 | 20 | 2 | int:CPLANE1 | |
| Interaction | RPL38 interactions | 2.91e-04 | 334 | 20 | 4 | int:RPL38 | |
| Interaction | SOX2 interactions | 2.93e-04 | 1422 | 20 | 7 | int:SOX2 | |
| Interaction | CCAR2 interactions | 3.01e-04 | 337 | 20 | 4 | int:CCAR2 | |
| Interaction | KMT2C interactions | 3.02e-04 | 134 | 20 | 3 | int:KMT2C | |
| Interaction | UPF3B interactions | 3.15e-04 | 136 | 20 | 3 | int:UPF3B | |
| Interaction | CTNNB1 interactions | 3.28e-04 | 1009 | 20 | 6 | int:CTNNB1 | |
| Interaction | NAP1L1 interactions | 3.29e-04 | 345 | 20 | 4 | int:NAP1L1 | |
| Interaction | PHF10 interactions | 3.36e-04 | 139 | 20 | 3 | int:PHF10 | |
| Interaction | LSM3 interactions | 3.36e-04 | 139 | 20 | 3 | int:LSM3 | |
| Interaction | YWHAB interactions | 3.37e-04 | 1014 | 20 | 6 | int:YWHAB | |
| Interaction | FLNA interactions | 3.51e-04 | 648 | 20 | 5 | int:FLNA | |
| Interaction | NFIB interactions | 3.58e-04 | 142 | 20 | 3 | int:NFIB | |
| Interaction | NCOA6 interactions | 3.80e-04 | 145 | 20 | 3 | int:NCOA6 | |
| Interaction | ITIH4 interactions | 4.28e-04 | 31 | 20 | 2 | int:ITIH4 | |
| Interaction | TLE3 interactions | 4.56e-04 | 376 | 20 | 4 | int:TLE3 | |
| Interaction | TRERF1 interactions | 4.85e-04 | 33 | 20 | 2 | int:TRERF1 | |
| Interaction | HIP1R interactions | 4.98e-04 | 159 | 20 | 3 | int:HIP1R | |
| Interaction | KDM6A interactions | 5.26e-04 | 162 | 20 | 3 | int:KDM6A | |
| Interaction | GAS2L3 interactions | 5.46e-04 | 35 | 20 | 2 | int:GAS2L3 | |
| Interaction | MSI2 interactions | 5.84e-04 | 168 | 20 | 3 | int:MSI2 | |
| Interaction | KMT2D interactions | 5.95e-04 | 169 | 20 | 3 | int:KMT2D | |
| Interaction | TRAPPC14 interactions | 6.10e-04 | 37 | 20 | 2 | int:TRAPPC14 | |
| Interaction | EGR2 interactions | 6.15e-04 | 171 | 20 | 3 | int:EGR2 | |
| Interaction | SPTBN2 interactions | 6.26e-04 | 172 | 20 | 3 | int:SPTBN2 | |
| Interaction | SNRPD2 interactions | 6.55e-04 | 414 | 20 | 4 | int:SNRPD2 | |
| Interaction | RBM15 interactions | 6.58e-04 | 175 | 20 | 3 | int:RBM15 | |
| Interaction | SP2 interactions | 6.78e-04 | 39 | 20 | 2 | int:SP2 | |
| Interaction | KRT15 interactions | 6.91e-04 | 178 | 20 | 3 | int:KRT15 | |
| Interaction | SPTBN1 interactions | 6.98e-04 | 421 | 20 | 4 | int:SPTBN1 | |
| Interaction | RPS15 interactions | 7.10e-04 | 423 | 20 | 4 | int:RPS15 | |
| Interaction | E2F7 interactions | 7.14e-04 | 40 | 20 | 2 | int:E2F7 | |
| Interaction | EXOSC2 interactions | 7.14e-04 | 180 | 20 | 3 | int:EXOSC2 | |
| Interaction | RPL27 interactions | 7.62e-04 | 431 | 20 | 4 | int:RPL27 | |
| Interaction | PSMD2 interactions | 7.88e-04 | 435 | 20 | 4 | int:PSMD2 | |
| Interaction | RPL36A interactions | 8.10e-04 | 188 | 20 | 3 | int:RPL36A | |
| Interaction | NFIA interactions | 8.10e-04 | 188 | 20 | 3 | int:NFIA | |
| Interaction | THRAP3 interactions | 8.44e-04 | 443 | 20 | 4 | int:THRAP3 | |
| Interaction | GTPBP4 interactions | 8.44e-04 | 443 | 20 | 4 | int:GTPBP4 | |
| Interaction | NOP16 interactions | 8.48e-04 | 191 | 20 | 3 | int:NOP16 | |
| Interaction | RPL18A interactions | 8.73e-04 | 447 | 20 | 4 | int:RPL18A | |
| Interaction | AKAP8 interactions | 8.74e-04 | 193 | 20 | 3 | int:AKAP8 | |
| Interaction | KLF5 interactions | 9.01e-04 | 195 | 20 | 3 | int:KLF5 | |
| Interaction | LTV1 interactions | 9.14e-04 | 196 | 20 | 3 | int:LTV1 | |
| Interaction | ZNF281 interactions | 9.28e-04 | 197 | 20 | 3 | int:ZNF281 | |
| Interaction | PWP1 interactions | 9.41e-04 | 198 | 20 | 3 | int:PWP1 | |
| Interaction | TRMT1L interactions | 9.83e-04 | 201 | 20 | 3 | int:TRMT1L | |
| Interaction | PYGO2 interactions | 1.03e-03 | 48 | 20 | 2 | int:PYGO2 | |
| Interaction | MRPL41 interactions | 1.04e-03 | 205 | 20 | 3 | int:MRPL41 | |
| Interaction | RFC5 interactions | 1.06e-03 | 206 | 20 | 3 | int:RFC5 | |
| Interaction | POLDIP2 interactions | 1.10e-03 | 209 | 20 | 3 | int:POLDIP2 | |
| Interaction | G3BP1 interactions | 1.11e-03 | 835 | 20 | 5 | int:G3BP1 | |
| Interaction | NFIC interactions | 1.12e-03 | 210 | 20 | 3 | int:NFIC | |
| Interaction | TUBA1C interactions | 1.12e-03 | 478 | 20 | 4 | int:TUBA1C | |
| Interaction | NANOG interactions | 1.15e-03 | 481 | 20 | 4 | int:NANOG | |
| Interaction | GSN interactions | 1.15e-03 | 212 | 20 | 3 | int:GSN | |
| Interaction | TRIP12 interactions | 1.18e-03 | 214 | 20 | 3 | int:TRIP12 | |
| Interaction | MRPL23 interactions | 1.26e-03 | 219 | 20 | 3 | int:MRPL23 | |
| Interaction | MRPS14 interactions | 1.28e-03 | 220 | 20 | 3 | int:MRPS14 | |
| Interaction | SPTAN1 interactions | 1.28e-03 | 496 | 20 | 4 | int:SPTAN1 | |
| Interaction | HDAC2 interactions | 1.30e-03 | 865 | 20 | 5 | int:HDAC2 | |
| Interaction | TUT1 interactions | 1.35e-03 | 55 | 20 | 2 | int:TUT1 | |
| Interaction | YWHAZ interactions | 1.36e-03 | 1319 | 20 | 6 | int:YWHAZ | |
| Interaction | IGF2BP1 interactions | 1.40e-03 | 508 | 20 | 4 | int:IGF2BP1 | |
| Interaction | KLF3 interactions | 1.41e-03 | 228 | 20 | 3 | int:KLF3 | |
| Interaction | FOXC1 interactions | 1.41e-03 | 228 | 20 | 3 | int:FOXC1 | |
| Interaction | SEPTIN7 interactions | 1.41e-03 | 228 | 20 | 3 | int:SEPTIN7 | |
| Interaction | DYNLL1 interactions | 1.42e-03 | 510 | 20 | 4 | int:DYNLL1 | |
| Interaction | RPS20 interactions | 1.45e-03 | 513 | 20 | 4 | int:RPS20 | |
| Interaction | XRCC5 interactions | 1.47e-03 | 515 | 20 | 4 | int:XRCC5 | |
| Interaction | CCT4 interactions | 1.47e-03 | 515 | 20 | 4 | int:CCT4 | |
| GeneFamily | SRY-boxes | 8.10e-05 | 19 | 13 | 2 | 757 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.42e-04 | 25 | 13 | 2 | 775 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 6.44e-04 | 53 | 13 | 2 | 532 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.09e-05 | 163 | 20 | 3 | a09449a502627aa369db600dba5bda93de7ce5c0 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD141+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 5.66e-05 | 169 | 20 | 3 | a4204bdd75837f5fee9aaac459cb4c19ee2a7bf4 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-basal_late|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.61e-05 | 178 | 20 | 3 | 03f22485074b3cbf9a6ad4d543c5bbfa826dc741 | |
| ToppCell | Epithelial-basal_cell|World / Lineage, Cell type, age group and donor | 6.72e-05 | 179 | 20 | 3 | d9be6647ec7b22747dc00dce4ea307b6af412dfa | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-basal_late|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.83e-05 | 180 | 20 | 3 | 255097d8eb244a32eb2ecd0e7e48e1a20bafb5cd | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_NK-T_NK-ILC_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.83e-05 | 180 | 20 | 3 | a999a6d219a8e58a8b63802ddf8c95ffaab9cfa0 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.17e-05 | 183 | 20 | 3 | 8330c39184ce076e1f95fd3725b68af551d89db0 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-basal_proximal|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.29e-05 | 184 | 20 | 3 | 575de705053da8b289670b5c40c1627c0833b5ed | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_neuroendocrine2[NE2]_(12)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.53e-05 | 186 | 20 | 3 | c7983281a290201567b398e9ea6baddb96c692bb | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.77e-05 | 188 | 20 | 3 | 3cfba3addcc9058f4ec31ad96261f79988f551a0 | |
| ToppCell | facs-Lung-EPCAM-18m-Epithelial-Basal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-05 | 189 | 20 | 3 | 783c1db856f2defe6f3b8748dd0bc29a8102f6d1 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-05 | 189 | 20 | 3 | 258ef4a52f90236dbed92f325ca033c8fa6156a5 | |
| ToppCell | facs-Lung-EPCAM-18m-Epithelial-respiratory_basal_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.89e-05 | 189 | 20 | 3 | 88b72fafbe58463543e0818f27f3dd9e5b4d34d2 | |
| ToppCell | facs-Lung-18m-Epithelial-airway_epithelial-respiratory_basal_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.02e-05 | 190 | 20 | 3 | 47e07ea22733306d8885ee9e5f0b033e2f5e2afb | |
| ToppCell | facs-Lung-18m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_bronchioalveolar_tree|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.02e-05 | 190 | 20 | 3 | 261b8afddfdcba4f70b50df126cef7ad00a0aae0 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.14e-05 | 191 | 20 | 3 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.27e-05 | 192 | 20 | 3 | 24d28e28a5c54ca7770f7e5ad7f4d00039e0aaf9 | |
| ToppCell | facs-Lung-EPCAM-18m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.27e-05 | 192 | 20 | 3 | 12096302a3a4d26e21ca04357aa557143f482155 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.40e-05 | 193 | 20 | 3 | 739fb2a57772a800a2e94bdd6c71285bb2c162a7 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-basal_intermediate_|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.40e-05 | 193 | 20 | 3 | 83d2dd823808a2b5ca1a6889eefb541ec042b24c | |
| ToppCell | 18-Airway-Epithelial-Basal_cell|Airway / Age, Tissue, Lineage and Cell class | 8.40e-05 | 193 | 20 | 3 | 5067b0db24f96e26cf3f9437736415f694e7a614 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.53e-05 | 194 | 20 | 3 | 7b2b40a56eb9c7203ca50133b2da4fd8fdd4a5cf | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.53e-05 | 194 | 20 | 3 | 6b286992d4bb56013c0ea5a7601d3476d806175a | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.53e-05 | 194 | 20 | 3 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.66e-05 | 195 | 20 | 3 | d673f8844896d5c7b76a7bc7f6b88a039f1bc263 | |
| ToppCell | facs-Lung-18m-Epithelial-airway_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.66e-05 | 195 | 20 | 3 | ed052c6d3dc104b02e34b645abfdee477af050c6 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_basal-Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.79e-05 | 196 | 20 | 3 | c5adab88140a465698abcbedc6505a43cae7bfd1 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids|BALF-PFMC / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.92e-05 | 197 | 20 | 3 | 495bfdb40b640591fbbaaa99f419bb6468cef405 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.92e-05 | 197 | 20 | 3 | ac9c0c25cfeaabd53d332982c73fc6c47b0c6478 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.92e-05 | 197 | 20 | 3 | b57d2e3413ef6dd1da56c45087926f2f3eab876c | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_TRM/EMRA|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.06e-05 | 198 | 20 | 3 | 90863377ed36afc30bc1a068612ad1adc77af5a8 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.06e-05 | 198 | 20 | 3 | 9a12e5e47236433e512c668005fe3f8be6fde95c | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.06e-05 | 198 | 20 | 3 | d021d0edb6aba2f15c51a3ec4e08c7233d0c1962 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.33e-05 | 200 | 20 | 3 | afac850d5a40de0d6f02857cf81a19443d90b1eb | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_basal-Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.33e-05 | 200 | 20 | 3 | 9da214f756a03516eaafde00289b90f69623b9f3 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-gdT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.33e-05 | 200 | 20 | 3 | 1779a8ff4443a85ac500f849764e86d9c7529b84 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.33e-05 | 200 | 20 | 3 | 2a9d715aba8bdef2341b0d44ff60825c074a4b03 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal-Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.33e-05 | 200 | 20 | 3 | 0594ca7bc313b73e1dc800cf058f8f798b0284cb | |
| ToppCell | droplet-Heart-4Chambers-21m-Hematologic-erythrocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.97e-04 | 74 | 20 | 2 | 6f222ebf7cb106bbb2ae3fb3cda660dfec3ea5d0 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Gpr50|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.23e-04 | 101 | 20 | 2 | 6523c314166dcf66c3ed13c02ca4b886b068e5b8 | |
| ToppCell | droplet-Heart-nan-24m-Endothelial-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-03 | 115 | 20 | 2 | e11128262ba1e2a7053b1b6c039f1aab37d2ce27 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.21e-03 | 116 | 20 | 2 | a07f16917c66ce25f23ebef350d693cc4c324075 | |
| ToppCell | BAL-Control-cDC_7|Control / Compartment, Disease Groups and Clusters | 1.32e-03 | 121 | 20 | 2 | b49b044a687a31883dfccecf10a183b5ba567f7a | |
| ToppCell | (5)_Dendritic_cell-(51)_cDC1|(5)_Dendritic_cell / shred on Cell_type and subtype | 1.36e-03 | 123 | 20 | 2 | d46cfdf8b3e561d8db33903207d5151cdb2a91d4 | |
| ToppCell | Lymphoid-T_cells_(Cd8+_T_cell)|World / shred on cell class and cell subclass (v4) | 1.74e-03 | 139 | 20 | 2 | c85f50fb536f4df6fa4dbdebe48e1ecea1df1121 | |
| ToppCell | AT1-AT2_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.76e-03 | 140 | 20 | 2 | 45d52a086ced8d58e01ac51ac4a90338e8649b16 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-03 | 140 | 20 | 2 | e64f6aa57bc069cfe970089bd1c298433bfaf771 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.84e-03 | 143 | 20 | 2 | 091708a47ac55c6585923ee30190ff296fa87f6f | |
| ToppCell | mild_COVID-19_(asymptomatic)-Treg|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.89e-03 | 145 | 20 | 2 | 2d0903009e918500facfd017ff31f2cec1e76131 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.89e-03 | 145 | 20 | 2 | 37580218f6a6f65a1d827cbcf59465f8827f9a55 | |
| ToppCell | mild_COVID-19_(asymptomatic)-Treg|World / disease group, cell group and cell class (v2) | 1.89e-03 | 145 | 20 | 2 | a3b0e1d0ce0caa8b281a146439d6455db64cc3e5 | |
| ToppCell | Adult-Immune-dendritic_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.94e-03 | 147 | 20 | 2 | 7cc4f74dd7a86247db8dc049ed7eadeb53825a96 | |
| ToppCell | E18.5-samps-Epithelial-Epithelial-non_alveolar-Club_cell|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.99e-03 | 149 | 20 | 2 | 82edfecb7981d8c336cf9da7aa7e2b3f7a017a3f | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_dendritic-myeloid_dendritic_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.99e-03 | 149 | 20 | 2 | 71d72a6e7b128ee96161e08f6a0d77be925e73a1 | |
| ToppCell | E18.5-samps-Epithelial-Epithelial-non_alveolar|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.99e-03 | 149 | 20 | 2 | 14a01ae540db8a350ea26a350b2e6ce6c07639d9 | |
| ToppCell | droplet-Heart-4Chambers-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-03 | 149 | 20 | 2 | 38890ddde0979977c8350f01497f1245ab51641a | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_D2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.02e-03 | 150 | 20 | 2 | ecc4fc94958cf2378dd003966dccba81b3c00f8e | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic-NK_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-03 | 151 | 20 | 2 | 3d07b79ecbcfad13116f0f2b039bd181a7ffe853 | |
| ToppCell | Transverse-Dendritic_cell-cDC1|Dendritic_cell / Region, Cell class and subclass | 2.04e-03 | 151 | 20 | 2 | 6870f3b5d2bfad849c3203658b5f28f0ae181295 | |
| ToppCell | droplet-Fat-Scat-21m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-03 | 151 | 20 | 2 | 79827a76c675dcb82f59c0a45d0f962b02d5bfd6 | |
| ToppCell | COVID-19_Severe-multiplets|COVID-19_Severe / disease group, cell group and cell class | 2.07e-03 | 152 | 20 | 2 | 451745151322c2fcea22dbb3dba681e12634a510 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.10e-03 | 153 | 20 | 2 | 88ca2d2c2ab19fbee13e18951b993ee05dd30f67 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.10e-03 | 153 | 20 | 2 | 553dff9688a1996d8f4ba16e60c683593d781389 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-03 | 154 | 20 | 2 | ce4b1e878cd88065fbfd2df18caf19703fec37d8 | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.12e-03 | 154 | 20 | 2 | e65e4636646164610f33f7bbac0d879a3ea55986 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_D2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.12e-03 | 154 | 20 | 2 | 8dc8f02534c3ebda30bf9e702e36d0c53d89e5a5 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.12e-03 | 154 | 20 | 2 | 5967a0a33456d5930fc492a700ebb015ac050abb | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.15e-03 | 155 | 20 | 2 | 105d59d8a1bb8cb37eef2c1767d737b2108ac7c5 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.15e-03 | 155 | 20 | 2 | a4ff78e2efc6fe9a513bb2b64e5848f2ce65a09f | |
| ToppCell | Monocytes-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 2.15e-03 | 155 | 20 | 2 | 82abfcee23ba08a1eb4208d367393285026e5388 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.15e-03 | 155 | 20 | 2 | fab281db4c275d51240b122be78713c839ba5a95 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Lymphocytic|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-03 | 156 | 20 | 2 | 39aa3adbee9f04cdc0055487d393edfa515e062b | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Lymphocytic-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-03 | 156 | 20 | 2 | a09e3aefe78d63ad5428ad48c6f83e547eb819f6 | |
| ToppCell | severe_COVID-19-cDC|severe_COVID-19 / disease group, cell group and cell class (v2) | 2.21e-03 | 157 | 20 | 2 | ec1978e07e2214048d015d8bb793c1d9991f6e37 | |
| ToppCell | facs-MAT-Fat-18m-Lymphocytic-NK_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-03 | 157 | 20 | 2 | e6846ffd1bb18bf0469bc6d49ab6cf3533d9cde6 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-cDC1|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.23e-03 | 158 | 20 | 2 | 78a8a498a9c84ed65e0eefaac781d5247c5b477a | |
| ToppCell | Fetal_29-31_weeks-Immune-mast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.23e-03 | 158 | 20 | 2 | 0c27c475289c70b17b6a66fc71f628511c5f0ae1 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-basal_intermediate_|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.23e-03 | 158 | 20 | 2 | 98712ed7e8e65e8c5ff9318cf0e0a04e271a055d | |
| ToppCell | Control-Myeloid-Monocytes,_Macrophages-Mast-cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.26e-03 | 159 | 20 | 2 | 81782e9e370558d61af5e0c760ac9759d69fb725 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.26e-03 | 159 | 20 | 2 | ded4e3626a62fb6334403b7213b467fb7e8131c3 | |
| ToppCell | Club_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.26e-03 | 159 | 20 | 2 | a7bcff268b1962a561fd2848e01ae16565bce895 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Lymphocytic-mature_NK_T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-03 | 159 | 20 | 2 | 32d4c9f7ba6a96ce8443396b80568b41cbfc4927 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.26e-03 | 159 | 20 | 2 | 2f6c60ddff2208a68146f9786143d9aefd528840 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.29e-03 | 160 | 20 | 2 | 028b5261a1da832d52f66fb620db83e5fbbd874a | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.29e-03 | 160 | 20 | 2 | b4844a8c7755a2b2868019791d8d224154973445 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l44|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.29e-03 | 160 | 20 | 2 | 6b0faaa371650563f585722f5b2fb319e124ec38 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.29e-03 | 160 | 20 | 2 | 1f4ee446436726c3d373f56d87dd80b6a12e8b9e | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-LMPP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.29e-03 | 160 | 20 | 2 | 60fa1c717410aad7e8647703cb416cd7617cac29 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.29e-03 | 160 | 20 | 2 | 01ae730e9d0d05f3277f862f0c09bafb32b89db5 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Neurosecretory|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.29e-03 | 160 | 20 | 2 | 6de9e7be1d860d82d503bfbc779e72f072a6efc3 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.32e-03 | 161 | 20 | 2 | b24293fdae9637983fcf4f2d4659a3554e00a53f | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.32e-03 | 161 | 20 | 2 | afc719ffa53ab34c5628da47936da1f731dceab1 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.32e-03 | 161 | 20 | 2 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.32e-03 | 161 | 20 | 2 | 41a89a3d99a9bd6039a3d881d1d9dcd18bc07f25 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.32e-03 | 161 | 20 | 2 | c4970501c038ed36de447da70eabff020ad78713 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic-DC1|bone_marrow / Manually curated celltypes from each tissue | 2.32e-03 | 161 | 20 | 2 | 2f068ee643de2f647c289779a6624265ab9a749b | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.32e-03 | 161 | 20 | 2 | 6d9907e2949a742c0933128fde57832a9ca5f77c | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-03 | 162 | 20 | 2 | 5731f9514434296132df4bc86f78ce87b07cdeca | |
| ToppCell | AT1_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.35e-03 | 162 | 20 | 2 | ae2ba4f21f6f6c512006fa531d670b88be7c04c9 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-03 | 162 | 20 | 2 | 0321fc954ae4ad67ca438cbbc84632562d222188 | |
| Disease | holoprosencephaly (is_implicated_in) | 1.22e-05 | 8 | 20 | 2 | DOID:4621 (is_implicated_in) | |
| Disease | intracranial aneurysm (is_implicated_in) | 2.87e-05 | 12 | 20 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | Lymphoma, Large-Cell, Follicular | 4.56e-05 | 15 | 20 | 2 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 4.56e-05 | 15 | 20 | 2 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 4.56e-05 | 15 | 20 | 2 | C0079758 | |
| Disease | Lymphoma, Follicular, Grade 2 | 4.56e-05 | 15 | 20 | 2 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 4.56e-05 | 15 | 20 | 2 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 4.56e-05 | 15 | 20 | 2 | C1956130 | |
| Disease | Lymphoma, Follicular | 8.23e-05 | 20 | 20 | 2 | C0024301 | |
| Disease | Bladder Neoplasm | 1.12e-04 | 140 | 20 | 3 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 1.15e-04 | 141 | 20 | 3 | C0005684 | |
| Disease | ejection fraction measurement | 3.88e-04 | 43 | 20 | 2 | EFO_0005527 | |
| Disease | Prostatic Neoplasms | 6.98e-04 | 616 | 20 | 4 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 6.98e-04 | 616 | 20 | 4 | C0376358 | |
| Disease | rheumatoid arthritis, ACPA-positive rheumatoid arthritis, rheumatoid factor seropositivity measurement | 8.32e-04 | 63 | 20 | 2 | EFO_0000685, EFO_0007791, EFO_0009459 | |
| Disease | cholangiocarcinoma (is_marker_for) | 8.58e-04 | 64 | 20 | 2 | DOID:4947 (is_marker_for) | |
| Disease | sclerosing cholangitis | 9.12e-04 | 66 | 20 | 2 | EFO_0004268 | |
| Disease | schizophrenia (implicated_via_orthology) | 9.68e-04 | 68 | 20 | 2 | DOID:5419 (implicated_via_orthology) | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 1.14e-03 | 74 | 20 | 2 | DOID:3748 (is_marker_for) | |
| Disease | Squamous cell carcinoma of esophagus | 1.88e-03 | 95 | 20 | 2 | C0279626 | |
| Disease | spontaneous preterm birth | 2.12e-03 | 101 | 20 | 2 | EFO_0006917 | |
| Disease | malaria | 2.16e-03 | 102 | 20 | 2 | EFO_0001068 | |
| Disease | treatment-resistant hypertension | 2.46e-03 | 109 | 20 | 2 | EFO_1002006 | |
| Disease | rheumatoid arthritis | 3.57e-03 | 462 | 20 | 3 | EFO_0000685 | |
| Disease | Neoplastic Cell Transformation | 3.96e-03 | 139 | 20 | 2 | C0007621 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RQEPQGQEHQGGENH | 71 | Q9Y2J4 | |
| MHHGTGPQNVQHQLQ | 1 | Q96L91 | |
| ANAQIHGPASQHMGN | 606 | O14490 | |
| GMAVENGHPVQQHQK | 1096 | Q9HBD1 | |
| RNNMMNIANGPHHPN | 286 | Q02297 | |
| QAQQHRGGGPQAQSH | 81 | Q7L2J0 | |
| MLQQVNGHNPGSDGQ | 1 | Q96H55 | |
| VQQQDHHPSQQGQGG | 66 | Q9UGJ1 | |
| MGGPQDPHTFNHQNL | 591 | Q53ET0 | |
| GGVMNLNPGNNLLHQ | 6 | Q9NZC4 | |
| GIIANRGQHFHGQNM | 56 | O43820 | |
| PQHPGLNAHGAAQMQ | 181 | P48431 | |
| GGGRGFQMQPQHQHQ | 306 | Q9H6I2 | |
| NHSVQNRDHRGGMQP | 251 | Q7Z7G1 | |
| CQHPNQRMGPGAHRG | 736 | P21580 | |
| GPNRMNGHHQQNGVE | 66 | Q8N3U4 | |
| GQASQREGHLQQGNM | 291 | A8MX80 | |
| PGPNQMSGHHDSNRQ | 111 | Q9NWH7 | |
| HGPHGSQNVLNGQMR | 166 | O95409 | |
| PSGIHLNNMGPQHQQ | 456 | Q96PN7 | |
| SNQGHMLSGQHGGQA | 3351 | O14686 |